Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Graft-Versus-Host Disease

Association between single nucleotide polymorphisms of tumor necrosis factor gene and grade II–IV acute GvHD: a systematic review and meta-analysis

Bone Marrow Transplantation volume 52, pages 1423–1427 (2017)Cite this article

Subjects

Abstract

Acute GvHD (aGvHD) complicates up to 50% of allogeneic hematopoietic cell transplants and pre-transplant estimation of its risk can guide prophylaxis, monitoring and early intervention strategies. Inspired by the role of tumor necrosis factor alpha (TNFα) in the pathogenesis of aGvHD and the inconsistency of the association studies exploring single nucleotide polymorphisms (SNPs) of the TNF gene, we conducted a systematic review and meta-analysis of the available reports using PubMed and EMBASE. Original human studies reporting on the association between recipient TNF SNPs and grade II–IV aGvHD in a format convertible to effect size and confidence interval were included. One of the two most widely investigated SNPs (rs361525G>A) was marginally associated with increased risk of grade II–IV aGvHD in random-effects meta-analysis of six studies (627 patients in total, risk ratio=1.29, 95% confidence interval=0.99–1.69, P=0.06). If this result is validated in a large cohort with uniform conditioning and GvHD prophylaxis, TNF rs361525G>A may become a useful tool for aGvHD risk estimation before the transplant.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Holtan SG, Pasquini M, Weisdorf DJ . Acute graft-versus-host disease: a bench-to-bedside update. Blood 2014; 124: 363–373.

    Article  CAS  Google Scholar 

  2. Pidala J, Anasetti C . Glucocorticoid-refractory acute graft-versus-host disease. Biol Blood Marrow Transplant 2010; 16: 1504–1518.

    Article  Google Scholar 

  3. Rashidi A, DiPersio JF, Sandmaier BM, Colditz GA, Weisdorf DJ . Steroids versus steroids plus additional agent in frontline treatment of acute graft-versus-host disease: a systematic review and meta-analysis of randomized trials. Biol Blood Marrow Transplant 2016; 22: 1133–1137.

    Article  CAS  Google Scholar 

  4. Chien JW, Zhang XC, Fan W, Wang H, Zhao LP, Martin PJ et al. Evaluation of published single nucleotide polymorphisms associated with acute GvHD. Blood 2012; 119: 5311–5319.

    Article  CAS  Google Scholar 

  5. Vassalli P . The pathophysiology of tumor necrosis factors. Annu Rev Immunol 1992; 10: 411–452.

    Article  CAS  Google Scholar 

  6. Facon T, Jouet JP, Noel-Walter MP, Bloget F, Bauters F, Janin A . Involvement of TNF-alpha secreting macrophages in lethal forms of human graft-versus-host disease. Bone Marrow Transplant 1997; 20: 511–515.

    Article  CAS  Google Scholar 

  7. Nestel FP, Price KS, Seemayer TA, Lapp WS . Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease. J Exp Med 1992; 175: 405–413.

    Article  CAS  Google Scholar 

  8. Hill GR, Ferrara JL . The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood 2000; 95: 2754–2759.

    CAS  Google Scholar 

  9. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339: b2535.

    Article  Google Scholar 

  10. National Heart Lung and Blood Institute. Quality assessment tool for observational cohort and cross-sectional studies, https://www.nhlbi.nih.gov/health-pro/guidelines/in-develop/cardiovascular-risk-reduction/tools/cohort, 2014.

  11. DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177–188.

    Article  CAS  Google Scholar 

  12. Higgins JP, Thompson SG, Deeks JJ, Altman DG . Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557–560.

    Article  Google Scholar 

  13. Bertinetto FE, Dall'Omo AM, Mazzola GA, Rendine S, Berrino M, Bertola L et al. Role of non-HLA genetic polymorphisms in graft-versus-host disease after haematopoietic stem cell transplantation. Int J Immunogenet 2006; 33: 375–384.

    Article  CAS  Google Scholar 

  14. Gan GG, Leong YC, Bee PC, Chin EF, Abdul Halim H, Nadarajan VS et al. Influence of genetic polymorphisms of cytokine genes in the outcome of HLA-matched allogeneic stem cell transplantation in a South East Asian population. Cytokine 2016; 78: 55–61.

    Article  CAS  Google Scholar 

  15. Goyal RK, Lin Y, Schultz KR, Ferrell RE, Kim Y, Fairfull L et al. Tumor necrosis factor-alpha gene polymorphisms are associated with severity of acute graft-versus-host disease following matched unrelated donor bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium study. Biol Blood Marrow Transplant 2010; 16: 927–936.e921.

    Article  CAS  Google Scholar 

  16. Mullighan C, Heatley S, Doherty K, Szabo F, Grigg A, Hughes T et al. Non-HLA immunogenetic polymorphisms and the risk of complications after allogeneic hemopoietic stem-cell transplantation. Transplantation 2004; 77: 587–596.

    Article  CAS  Google Scholar 

  17. Middleton PG, Taylor PR, Jackson G, Proctor SJ, Dickinson AM . Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants. Blood 1998; 92: 3943–3948.

    CAS  PubMed  Google Scholar 

  18. Bogunia-Kubik K, Polak M, Lange A . TNF polymorphisms are associated with toxic but not with aGvHD complications in the recipients of allogeneic sibling haematopoietic stem cell transplantation. Bone Marrow Transplant 2003; 32: 617–622.

    Article  CAS  Google Scholar 

  19. Socie G, Loiseau P, Tamouza R, Janin A, Busson M, Gluckman E et al. Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Transplantation 2001; 72: 699–706.

    Article  CAS  Google Scholar 

  20. Viel DO, Tsuneto LT, Sossai CR, Lieber SR, Marques SB, Vigorito AC et al. IL2 and TNFA gene polymorphisms and the risk of graft-versus-host disease after allogeneic haematopoietic stem cell transplantation. Scand J Immunol 2007; 66: 703–710.

    Article  CAS  Google Scholar 

  21. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994Consensus conference on acute GvHD grading. Bone Marrow Transplant 1995; 15: 825–828.

    CAS  Google Scholar 

  22. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295–304.

    Article  CAS  Google Scholar 

  23. Holler E, Kolb HJ, Mittermuller J, Kaul M, Ledderose G, Duell T et al. Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNF alpha) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNF alpha (MAK 195F). Blood 1995; 86: 890–899.

    CAS  Google Scholar 

  24. Kitko CL, Paczesny S, Yanik G, Braun T, Jones D, Whitfield J et al. Plasma elevations of tumor necrosis factor-receptor-1 at day 7 postallogeneic transplant correlate with graft-versus-host disease severity and overall survival in pediatric patients. Biol Blood Marrow Transplant 2008; 14: 759–765.

    Article  Google Scholar 

  25. Holler E, Kolb HJ, Moller A, Kempeni J, Liesenfeld S, Pechumer H et al. Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. Blood 1990; 75: 1011–1016.

    CAS  Google Scholar 

  26. Herve P, Flesch M, Tiberghien P, Wijdenes J, Racadot E, Bordigoni P et al. Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease. Blood 1992; 79: 3362–3368.

    CAS  PubMed  Google Scholar 

  27. Silkov AN, Sennikova NS, Goreva EP, Lopatnikova YA, Sennikov SV . Production of TNF-α and IL-1β by peripheral blood mononuclear cells in carriers of different allele variants of the gene. Bull Exp Biol Med 2012; 153: 68–71.

    Article  CAS  Google Scholar 

  28. Hajeer AH, Hutchinson IV . Influence of TNFalpha gene polymorphisms on TNFalpha production and disease. Hum Immunol 2001; 62: 1191–1199.

    Article  CAS  Google Scholar 

  29. Hill GR, Crawford JM, Cooke KR, Brinson YS, Pan L, Ferrara JL . Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood 1997; 90: 3204–3213.

    CAS  PubMed  Google Scholar 

  30. Hallermalm K, Seki K, Wei C, Castelli C, Rivoltini L, Kiessling R et al. Tumor necrosis factor-alpha induces coordinated changes in major histocompatibility class I presentation pathway, resulting in increased stability of class I complexes at the cell surface. Blood 2001; 98: 1108–1115.

    Article  CAS  Google Scholar 

  31. Spellman S, Warden MB, Haagenson M, Pietz BC, Goulmy E, Warren EH et al. Effects of mismatching for minor histocompatibility antigens on clinical outcomes in HLA-matched, unrelated hematopoietic stem cell transplants. Biol Blood Marrow Transplant 2009; 15: 856–863.

    Article  CAS  Google Scholar 

  32. Carapito R, Jung N, Kwemou M, Untrau M, Michel S, Pichot A et al. Matching for the nonconventional MHC-I MICA gene significantly reduces the incidence of acute and chronic GvHD. Blood 2016; 128: 1979–1986.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Author contributions

AR had full access to all of the data in the study and he takes responsibility for the integrity and the accuracy of the data analysis. Study concept and design: AR; search strategy: AR; selection of the studies: AR and DJW; quality appraisal and data extraction: AR and DJW; analysis and interpretation of data: AR and DJW; drafting of the manuscript: AR; critical revision of the manuscript for important intellectual content: DJW.

Author information

Authors and Affiliations

  1. Division of Hematology, Department of Medicine, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USA

    A Rashidi & D Weisdorf

Authors
  1. A Rashidi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D Weisdorf
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A Rashidi.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rashidi, A., Weisdorf, D. Association between single nucleotide polymorphisms of tumor necrosis factor gene and grade II–IV acute GvHD: a systematic review and meta-analysis. Bone Marrow Transplant 52, 1423–1427 (2017). https://doi.org/10.1038/bmt.2017.144

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2017.144

This article is cited by

Search

Advanced search

Quick links